Coherent Sine Burst (CSE) Electroporation System Pilot Study in Patients With Atrial Fibrillation

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 101 participants.

Also called NCT05572047

  • Study
  • In this atlas

Overview

Design
Interventional study; allocation not applicable; no masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 101 participants (enrolled count) (from the registry)
Sponsor
Arga Medtech SA (from the registry)
Registry
  • NCT NCT05572047
Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
Croatia, Georgia (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT05572047. Allocation not applicable; no masking; primary purpose treatment. Start 2022-10-11 (actual); primary completion 2026-04-24 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Coherent Sine Burst (CSE) Electroporation System Pilot Study in Patients With Atrial Fibrillation
Acronym
BURST-AF
Intervention (Device)
Arga Medtech Coherent Sine-Burst Electroporation (CSE) Ablation System
Lead sponsor
Arga Medtech SA (class: industry)

Record details

Record id
cardio:ct-nct05572047
Content hash
82b84a39ac2fffb768b34f9a714f59e11b3276f8122b1bfc8440480d8719d469